Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Having bio-absorbable component
Reexamination Certificate
2000-02-25
2002-04-09
Szekely, Peter (Department: 1714)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Having bio-absorbable component
C623S001180, C623S001190, C623S001490, C623S925000, C623S926000, C604S264000, C424S078170, C424S422000, C523S105000, C523S113000, C523S124000, C524S028000, C524S043000, C524S044000, C524S045000, C524S047000, C524S503000, C524S918000, C525S903000
Reexamination Certificate
active
06368356
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to shaped medical devices comprising polymer hydrogels having improved mechanical properties. More particularly, the invention relates to shaped medical devices which can function as temporary implants which do not require additional surgical procedures for removal.
BACKGROUND OF THE INVENTION
Shaped medical devices for insertion and/or implantation into the body have a variety of applications including drug delivery, tissue engineering, vascular surgery (e.g., angioplasty) and drainage (e.g., from the kidney). Such devices include vascular grafts, stents, catheters, cannulas, plugs, constrictors, tissue scaffolds, and tissue or biological encapsulants, and the like.
Typically, many of these devices are made of durable, non-degradable plastic materials such as polyurethanes, polyacrylates, silicone polymers, and the like. Typical stents, for example, are permanent devices which require a surgical procedure to remove and may cause discomfort. Shaped medical devices have also been disclosed which are made from biodegradable polymers. These remain stable in vivo for a period of time but eventually biodegrade into small fragments which are removed by the body by normal elimination in the urine or feces. In the case of ureteral stents, the fragmentation of such biodegradeable polymers into small pieces can obstruct the ureter and cause patient discomfort.
Typical biodegradable polymers used in these devices include polyesters, polyanhydrides and polyorthoesters which undergo hydrolytic chain cleavage, as disclosed in U.S. Pat. No. 5,085,629, crosslinked polysaccharide hydrogel polymers as disclosed in U.S. Pat. No. 5,057,606, and other ionically crosslinked hydrogels, as disclosed in U.S. Pat. Nos. 4,941,870, 4,286,341 and 4,878,907, the entirety of which are incorporated herein by reference. Crosslinked polysaccharide hydrogel polymers also are disclosed in EPA 0507604 A2.
EPA 0645150 A-1 describes hydrogel medical devices prepared from ionically crosslinked anionic polymers (e.g., polysaccharides such as calcium alginate) or ionically crosslinked cationic polymers (e.g., chitosan, cationic guar, cationic starch, and polyethylene amine). These devices can be rapidly disintegrated in vivo upon the administration of a chemical trigger material which displaces the crosslinking ions.
Hydrogels are water-swollen polymers which offer excellent biocompatibility and have a decreased tendency to induce thrombosis, encrustation, and inflammation. Unfortunately, the use of hydrogels in medical device applications has often been hindered by poor mechanical performance. Although many medical device applications for hydrogels exist where minimal stresses are encountered by the device in vivo, most applications require that the device survive high stresses during implantation. Inferior mechanical properties result from the swollen nature of hydrogels and the non-stress bearing nature of the swelling agent (e.g., aqueous fluids). Hydrogels suffer from low modulus, low yield stress, and low strength, when compared to non-swollen polymer systems.
In addition, ion sequestrants within certain body fluids, such as the urine, will degrade the hydrogel too quickly, preventing the use of such hydrogels in ureteral stent applications since a hydrogel stent will not hold its strength long enough to allow the device to function. Further, the amount of sequestrants in the urine is very difficult to control, even with the use of certain diets. As a result, the performance of a hydrogel stent in the ureter is variable from patient to patient.
REFERENCES:
patent: 2485512 (1949-10-01), Rose
patent: 2541804 (1951-02-01), Wormell
patent: 2712672 (1955-07-01), Calcagno
patent: 2847713 (1958-08-01), Weingand
patent: 2897547 (1959-08-01), Weingand
patent: 3271496 (1966-09-01), Michaels
patent: 4137921 (1979-02-01), Okuzumi et al.
patent: 4286341 (1981-09-01), Greer et al.
patent: 4339295 (1982-07-01), Boretos et al.
patent: 4439322 (1984-03-01), Sonoda et al.
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4605691 (1986-08-01), Balazs et al.
patent: 4613517 (1986-09-01), Williams et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4650488 (1987-03-01), Bays et al.
patent: 4716154 (1987-12-01), Malson et al.
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4801475 (1989-01-01), Halpern et al.
patent: 4814120 (1989-03-01), Huc et al.
patent: 4838876 (1989-06-01), Wong et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4863907 (1989-09-01), Sakurai et al.
patent: 4878907 (1989-11-01), Okada et al.
patent: 4888016 (1989-12-01), Langerman
patent: 4902295 (1990-02-01), Walthall et al.
patent: 4906237 (1990-03-01), Johansson et al.
patent: 4923645 (1990-05-01), Tsang et al.
patent: 4941870 (1990-07-01), Okada et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 4965353 (1990-10-01), della Valle et al.
patent: 4997443 (1991-03-01), Walthall et al.
patent: 5057606 (1991-10-01), Garbe
patent: 5061738 (1991-10-01), Solomon et al.
patent: 5077352 (1991-12-01), Elton
patent: 5085629 (1992-02-01), Goldbert et al.
patent: 5089606 (1992-02-01), Cole et al.
patent: 5128326 (1992-07-01), Balazs et al.
patent: 5149543 (1992-09-01), Cohen et al.
patent: 5202431 (1993-04-01), della Valle et al.
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5298569 (1994-03-01), Yamamori et al.
patent: 5302393 (1994-04-01), Matsumoto et al.
patent: 5306764 (1994-04-01), Chen
patent: 5308701 (1994-05-01), Cohen et al.
patent: 5322935 (1994-06-01), Smith
patent: 5328939 (1994-07-01), Smith
patent: 5334640 (1994-08-01), Desai et al.
patent: 5413782 (1995-05-01), Warchol et al.
patent: 5514377 (1996-05-01), Cochrum et al.
patent: 5531716 (1996-07-01), Luzio et al.
patent: 5532305 (1996-07-01), Matsuzaki et al.
patent: 5554388 (1996-09-01), Illum
patent: 5650116 (1997-07-01), Thompson
patent: 5736595 (1998-04-01), Günther et al.
patent: 6096018 (2000-04-01), Luzio et al.
patent: 6126645 (2000-10-01), Thompson
patent: 2827289 (1979-01-01), None
patent: 0065884 (1982-12-01), None
patent: 0213908 (1987-03-01), None
patent: 0271216 (1988-06-01), None
patent: 0341745 (1989-11-01), None
patent: 080254 (1990-08-01), None
patent: 0454373 (1991-10-01), None
patent: 0507604 (1992-10-01), None
patent: 0645150 (1995-03-01), None
patent: 2151244 (1985-07-01), None
patent: 04145218 (1992-05-01), None
patent: 89/05671 (1989-06-01), None
patent: 90/10020 (1990-09-01), None
patent: 91/07200 (1991-05-01), None
patent: 92/13579 (1992-08-01), None
patent: 92/18098 (1992-10-01), None
patent: 93/09176 (1993-05-01), None
Andrade, Joseph D., “Hydrogels for Medical and Related Applications”, Aug. 27-28, 1975, pp. 1-36 (Editor, presented article at that time); AM. Chem. Soc. 1976.
Kocvara et al., “Gel-Fabric Prostheses of the Ureter”,Journal of Biomedical Research, vol. 1, pp. 325-336 (1967).
Ross, “Living Cure” (Science and the Citizen),Scientific American,Jun. 1993, pp. 18-23.
Godshall Douglas E.
Madenjian Arthur R.
Ronan John M.
Thompson Samuel A.
Zhong Sheng Ping
Sci-Med Life Systems, Inc.
Szekely Peter
Testa Hurwitz & Thibeault LLP
LandOfFree
Medical devices comprising hydrogel polymers having improved... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical devices comprising hydrogel polymers having improved..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical devices comprising hydrogel polymers having improved... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2838559